ERBB2 and cancer: It stabilizes key cancer-related proteins such as p53, HER-2 and hypoxia-inducible factor 1 (HIF1), making it a significant target for cancer therapies (Ren et al., 2014 ▸; Miyata et al., 2013 ▸).